Table of Content

1. Preface

1.1. Market Definition and Scope

1.2. Market Segmentation

1.3. Key Research Objectives

1.4. Research Highlights


2. Assumptions and Research Methodology


3. Executive Summary: Global Arthritis Therapeutics Market


4. Market Overview

4.1. Introduction

4.1.1. Market Definition

4.1.2. Industry Evolution / Developments

4.2. Overview

4.3. Market Dynamics

4.3.1. Drivers

4.3.2. Restraints

4.3.3. Opportunities

4.4. Global Arthritis Therapeutics Market Analysis and Forecast, 2017–2027

4.4.1. Market Revenue Projections (US$ Mn)


5. Key Insights

5.1. Key product/brand Analysis

5.2. Pipeline Analysis

5.3. Disease Prevalence & Incidence Rate globally with key countries

5.4. Regulatory Scenario by Region/globally


6. Global Arthritis Therapeutics Market Analysis and Forecast, By Type

6.1. Introduction & Definition

6.2. Key Findings / Developments

6.3. Arthritis Therapeutics Market Value (US$ Mn) Forecast, by Type, 2017–2027

6.3.1. Rheumatoid Arthritis

6.3.2. Osteoarthritis

6.3.3. Psoriatic Arthritis

6.3.4. Gout

6.3.5. Others

6.4. Market Attractiveness By Type


7. Global Arthritis Therapeutics Market Analysis and Forecast, By Drug Class

7.1. Introduction & Definition

7.2. Key Findings / Developments

7.3. Arthritis Therapeutics Market Value (US$ Mn) Forecast, by Drug Class, 2017–2027

7.3.1. TNF Inhibitors

7.3.2. Interleukin Inhibitors

7.3.3. NSAIDs

7.3.4. Corticosteroids

7.3.5. Xanthine Oxidase Inhibitors

7.3.6. Others

7.4. Market Attractiveness By Drug Class


8. Global Arthritis Therapeutics Market Analysis and Forecast, By Route of Administration

8.1. Introduction & Definition

8.2. Key Findings / Developments

8.3. Arthritis Therapeutics Market Value (US$ Mn) Forecast, by Route of Administration, 2017–2027

8.3.1. Oral

8.3.2. Parenteral

8.3.3. Topical

8.4. Market Attractiveness By Route of Administration


9. Global Arthritis Therapeutics Market Analysis and Forecast, By Distribution Channel

9.1. Introduction & Definition

9.2. Key Findings / Developments

9.3. Arthritis Therapeutics Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027

9.3.1. Hospital Pharmacies

9.3.2. Retail Pharmacies

9.3.3. Online Pharmacies

9.4. Market Attractiveness By Distribution Channel


10. Global Arthritis Therapeutics Market Analysis and Forecast, By Region

10.1. Key Findings

10.2. Arthritis Therapeutics Market Value (US$ Mn) Forecast, by Region

10.2.1. North America

10.2.2. Europe

10.2.3. Asia Pacific

10.2.4. Latin America

10.2.5. Middle East & Africa

10.3. Market Attractiveness By Country/Sub-region /Region


11. North America Arthritis Therapeutics Market Analysis and Forecast

11.1. Introduction

11.1.1. Key Findings

11.2. North America Arthritis Therapeutics Market Value (US$ Mn) Forecast, by Type, 2017–2027

11.2.1. Rheumatoid Arthritis

11.2.2. Osteoarthritis

11.2.3. Psoriatic Arthritis

11.2.4. Gout

11.2.5. Others

11.3. North America Arthritis Therapeutics Market Value (US$ Mn) Forecast, by Drug Class, 2017–2027

11.3.1. TNF Inhibitors

11.3.2. Interleukin Inhibitors

11.3.3. NSAIDs

11.3.4. Corticosteroids

11.3.5. Xanthine Oxidase Inhibitors

11.3.6. Others

11.4. North America Arthritis Therapeutics Market Value (US$ Mn) Forecast, by Route of Administration, 2017–2027

11.4.1. Oral

11.4.2. Parenteral

11.4.3. Topical

11.5. North America Arthritis Therapeutics Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027

11.5.1. Hospital Pharmacies

11.5.2. Retail Pharmacies

11.5.3. Online Pharmacies

11.6. North America Arthritis Therapeutics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

11.6.1. U.S.

11.6.2. Canada

11.7. North America Market Attractiveness Analysis

11.7.1. By Type

11.7.2. By Drug Class

11.7.3. By Route of Administration

11.7.4. By Distribution Channel

11.7.5. By Country/Sub-region


12. Europe Arthritis Therapeutics Market Analysis and Forecast

12.1. Introduction

12.1.1. Key Findings

12.2. Europe Arthritis Therapeutics Market Value (US$ Mn) Forecast, by Type, 2017–2027

12.2.1. Rheumatoid Arthritis

12.2.2. Osteoarthritis

12.2.3. Psoriatic Arthritis

12.2.4. Gout

12.2.5. Others

12.3. Europe Arthritis Therapeutics Market Value (US$ Mn) Forecast, by Drug Class, 2017–2027

12.3.1. TNF Inhibitors

12.3.2. Interleukin Inhibitors

12.3.3. NSAIDs

12.3.4. Corticosteroids

12.3.5. Xanthine Oxidase Inhibitors

12.3.6. Others

12.4. Europe Arthritis Therapeutics Market Value (US$ Mn) Forecast, by Route of Administration, 2017–2027

12.4.1. Oral

12.4.2. Parenteral

12.4.3. Topical

12.5. Europe Arthritis Therapeutics Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027

12.5.1. Hospital Pharmacies

12.5.2. Retail Pharmacies

12.5.3. Online Pharmacies

12.6. Europe Arthritis Therapeutics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

12.6.1. Germany

12.6.2. U.K.

12.6.3. France

12.6.4. Spain

12.6.5. Italy

12.6.6. Rest of Europe

12.7. Europe Market Attractiveness Analysis

12.7.1. By Type

12.7.2. By Drug Class

12.7.3. By Route of Administration

12.7.4. By Distribution Channel

12.7.5. By Country/Sub-region

13. Asia Pacific Arthritis Therapeutics Market Analysis and Forecast

13.1. Introduction

13.1.1. Key Findings

13.2. Asia Pacific Arthritis Therapeutics Market Value (US$ Mn) Forecast, by Type, 2017–2027

13.2.1. Rheumatoid Arthritis

13.2.2. Osteoarthritis

13.2.3. Psoriatic Arthritis

13.2.4. Gout

13.2.5. Others

13.3. Asia Pacific Arthritis Therapeutics Market Value (US$ Mn) Forecast, by Drug Class, 2017–2027

13.3.1. TNF Inhibitors

13.3.2. Interleukin Inhibitors

13.3.3. NSAIDs

13.3.4. Corticosteroids

13.3.5. Xanthine Oxidase Inhibitors

13.3.6. Others

13.4. Asia Pacific Arthritis Therapeutics Market Value (US$ Mn) Forecast, by Route of Administration, 2017–2027

13.4.1. Oral

13.4.2. Parenteral

13.4.3. Topical

13.5. Asia Pacific Arthritis Therapeutics Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027

13.5.1. Hospital Pharmacies

13.5.2. Retail Pharmacies

13.5.3. Online Pharmacies

13.6. Asia Pacific Arthritis Therapeutics Market Value (US$ Mn) Forecast, By Country/Sub-region /Sub-region, 2017–2027

13.6.1. China

13.6.2. Japan

13.6.3. India

13.6.4. Australia & New Zealand

13.6.5. Rest of Asia Pacific

13.7. Asia Pacific Market Attractiveness Analysis

13.7.1. By Type

13.7.2. By Drug Class

13.7.3. By Route of Administration

13.7.4. By Distribution Channel

13.7.5. By Country/Sub-region

14. Latin America Arthritis Therapeutics Market Analysis and Forecast

14.1. Introduction

14.1.1. Key Findings

14.2. Latin America Arthritis Therapeutics Market Value (US$ Mn) Forecast, by Type, 2017–2027

14.2.1. Rheumatoid Arthritis

14.2.2. Osteoarthritis

14.2.3. Psoriatic Arthritis

14.2.4. Gout

14.2.5. Others

14.3. Latin America Arthritis Therapeutics Market Value (US$ Mn) Forecast, by Drug Class, 2017–2027

14.3.1. TNF Inhibitors

14.3.2. Interleukin Inhibitors

14.3.3. NSAIDs

14.3.4. Corticosteroids

14.3.5. Xanthine Oxidase Inhibitors

14.3.6. Others

14.4. Latin America Arthritis Therapeutics Market Value (US$ Mn) Forecast, by Route of Administration, 2017–2027

14.4.1. Oral

14.4.2. Parenteral

14.4.3. Topical

14.5. Latin America Arthritis Therapeutics Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027

14.5.1. Hospital Pharmacies

14.5.2. Retail Pharmacies

14.5.3. Online Pharmacies

14.6. Latin America Arthritis Therapeutics Market Value (US$ Mn) Forecast, By Country/Sub-region /Sub-region, 2017–2027

14.6.1. Brazil

14.6.2. Mexico

14.6.3. Rest of Latin America

14.7. Latin America Market Attractiveness Analysis

14.7.1. By Type

14.7.2. By Drug Class

14.7.3. By Route of Administration

14.7.4. By Distribution Channel

14.7.5. By Country/Sub-region


15. Middle East & Africa Arthritis Therapeutics Market Analysis and Forecast

15.1. Introduction

15.1.1. Key Findings

15.2. Middle East & Africa Arthritis Therapeutics Market Value (US$ Mn) Forecast, by Type, 2017–2027

15.2.1. Rheumatoid Arthritis

15.2.2. Osteoarthritis

15.2.3. Psoriatic Arthritis

15.2.4. Gout

15.2.5. Others

15.3. Middle East & Africa Arthritis Therapeutics Market Value (US$ Mn) Forecast, by Drug Class, 2017–2027

15.3.1. TNF Inhibitors

15.3.2. Interleukin Inhibitors

15.3.3. NSAIDs

15.3.4. Corticosteroids

15.3.5. Xanthine Oxidase Inhibitors

15.3.6. Others

15.4. Middle East & Africa Arthritis Therapeutics Market Value (US$ Mn) Forecast, by Route of Administration, 2017–2027

15.4.1. Oral

15.4.2. Parenteral

15.4.3. Topical

15.5. Middle East & Africa Arthritis Therapeutics Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027

15.5.1. Hospital Pharmacies

15.5.2. Retail Pharmacies

15.5.3. Online Pharmacies

15.6. Middle East & Africa Arthritis Therapeutics Market Value (US$ Mn) Forecast, By Country/Sub-region , 2017–2027

15.6.1. GCC Countries

15.6.2. South Africa

15.6.3. Rest of Middle East & Africa

15.7. Middle East & Africa Market Attractiveness Analysis

15.7.1. By Type

15.7.2. By Drug Class

15.7.3. By Route of Administration

15.7.4. By Distribution Channel

15.7.5. By Country/Sub-region


16. Competition Landscape

16.1. Market Share Analysis By Company (2018)

16.2. Company Profiles

16.2.1. Novartis AG

16.2.1.1. Company Overview (HQ, Business Segments, Employee Strength)

16.2.1.2. Financial Overview

16.2.1.3. Product Portfolio

16.2.1.4. Strategic Overview

16.2.1.5. SWOT Analysis

16.2.2. Eli Lilly and Company

16.2.2.1. Company Overview (HQ, Business Segments, Employee Strength)

16.2.2.2. Financial Overview

16.2.2.3. Product Portfolio

16.2.2.4. Strategic Overview

16.2.2.5. SWOT Analysis

16.2.3. Amgen, Inc.

16.2.3.1. Company Overview (HQ, Business Segments, Employee Strength)

16.2.3.2. Financial Overview

16.2.3.3. Product Portfolio

16.2.3.4. Strategic Overview

16.2.3.5. SWOT Analysis

16.2.4. Merck & Co., Inc.

16.2.4.1. Company Overview (HQ, Business Segments, Employee Strength)

16.2.4.2. Financial Overview

16.2.4.3. Product Portfolio

16.2.4.4. Strategic Overview

16.2.4.5. SWOT Analysis

16.2.5. Bristol-Myers Squibb Company

16.2.5.1. Company Overview (HQ, Business Segments, Employee Strength)

16.2.5.2. Financial Overview

16.2.5.3. Product Portfolio

16.2.5.4. Strategic Overview

16.2.5.5. SWOT Analysis

16.2.6. Pfizer, Inc.

16.2.6.1. Company Overview (HQ, Business Segments, Employee Strength)

16.2.6.2. Financial Overview

16.2.6.3. Product Portfolio

16.2.6.4. Strategic Overview

16.2.6.5. SWOT Analysis

16.2.7. AbbVie, Inc.

16.2.7.1. Company Overview (HQ, Business Segments, Employee Strength)

16.2.7.2. Financial Overview

16.2.7.3. Product Portfolio

16.2.7.4. Strategic Overview

16.2.7.5. SWOT Analysis

16.2.8. Janssen Global Services, LLC (Johnson & Johnson)

16.2.8.1. Company Overview (HQ, Business Segments, Employee Strength)

16.2.8.2. Financial Overview

16.2.8.3. Product Portfolio

16.2.8.4. Strategic Overview

16.2.8.5. SWOT Analysis

16.2.9. F. Hoffmann-La Roche Ltd

16.2.9.1. Company Overview (HQ, Business Segments, Employee Strength)

16.2.9.2. Financial Overview

16.2.9.3. Product Portfolio

16.2.9.4. Strategic Overview

16.2.9.5. SWOT Analysis

16.2.10. Sanofi

16.2.10.1. Company Overview (HQ, Business Segments, Employee Strength)

16.2.10.2. Financial Overview

16.2.10.3. Product Portfolio

16.2.10.4. Strategic Overview

16.2.10.5. SWOT Analysis



List of Figures



Figure 01: Global Arthritis Therapeutics Market Snapshot

Figure 02: Global Arthritis Therapeutics Market Value (US$ Mn) and Distribution, by Region, 2018 and 2027

Figure 03: Global Arthritis Therapeutics Market Value (US$ Mn) Forecast, 2017?2027

Figure 04: Global Arthritis Therapeutics Market Value Share (%), by Type (2018)

Figure 05: Global Arthritis Therapeutics Market Value Share (%), by Route of Administration (2018)

Figure 06: Global Arthritis Therapeutics Market Value Share (%), by Drug Class (2018)

Figure 07: Global Arthritis Therapeutics Market Value Share (%), by Distribution Channel (2018)

Figure 08: Global Arthritis Therapeutics Market Value Share (%), by Region (2018)

Figure 09: Global Arthritis Therapeutics Market Value Share Analysis, by Type, 2018 and 2027

Figure 10: Global Arthritis Therapeutics Market Attractiveness, by Type, 2019–2027

Figure 11: Global Arthritis Therapeutics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Rheumatoid Arthritis, 2017–2027

Figure 12: Global Arthritis Therapeutics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Osteoarthritis, 2017–2027

Figure 13: Global Arthritis Therapeutics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Psoriatic Arthritis, 2017–2027

Figure 14: Global Arthritis Therapeutics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Gout, 2017–2027

Figure 15: Global Arthritis Therapeutics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Others, 2017–2027

Figure 16: Global Arthritis Therapeutics Market Value Share Analysis, by Drug Class, 2018 and 2027

Figure 17: Global Arthritis Therapeutics Market Attractiveness, by Drug Class, 2019–2027

Figure 18: Global Arthritis Therapeutics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by TNF Inhibitors, 2017–2027

Figure 19: Global Arthritis Therapeutics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Interleukin Inhibitors, 2017–2027

Figure 20: Global Arthritis Therapeutics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by NSAIDs, 2017–2027

Figure 21: Global Arthritis Therapeutics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Corticosteroids, 2017–2027

Figure 22: Global Arthritis Therapeutics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Xanthine Oxidase Inhibitors, 2017–2027

Figure 23: Global Arthritis Therapeutics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Others, 2017–2027

Figure 24: Global Arthritis Therapeutics Market Value Share(%), by Route of Administration, 2018 and 2027

Figure 25: Global Arthritis Therapeutics Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Oral, 2017–2027

Figure 26: Global Arthritis Therapeutics Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Parenteral, 2017–2027

Figure 27: Global Arthritis Therapeutics Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Topical, 2017–2027

Figure 28: Global Arthritis Therapeutics Market Attractiveness, by Route of Administration, 2019–2027

Figure 29: Global Arthritis Therapeutics Market Value Share (%), by Distribution Channel, 2018 and 2027

Figure 30: Global Arthritis Therapeutics Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Hospital Pharmacies, 2017–2027

Figure 31: Global Arthritis Therapeutics Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Retail Pharmacies, 2017–2027

Figure 32: Global Arthritis Therapeutics Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Online Pharmacies, 2017–2027

Figure 33: Global Arthritis Therapeutics Market Attractiveness, by Distribution Channel, 2019–2027

Figure 34: Global Arthritis Therapeutics Market Value Share Analysis, by Region 2018 and 2027

Figure 35: Global Arthritis Therapeutics Market Attractiveness, by Region, 2019–2027

Figure 36: North America Arthritis Therapeutics Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017–2027

Figure 37: North America Arthritis Therapeutics Market Value Share (%), by Type, 2018 and 2027

Figure 38: North America Arthritis Therapeutics Market Attractiveness, by Type, 2019–2027

Figure 39: North America Arthritis Therapeutics Market Value Share (%), by Drug Class, 2018 and 2027

Figure 40: North America Arthritis Therapeutics Market Attractiveness, by Drug Class, 2019–2027

Figure 41: North America Arthritis Therapeutics Market Value Share (%), by Route of Administration, 2018 and 2027

Figure 42: North America Arthritis Therapeutics Market Attractiveness, by Route of Administration, 2019–2027

Figure 43: North America Arthritis Therapeutics Market Value Share (%), by Distribution Channel, 2018 and 2027

Figure 44: North America Arthritis Therapeutics Market Attractiveness, by Distribution Channel, 2019–2027

Figure 45 : North America Arthritis Therapeutics Market Value Share (%), By Country/Sub-region , 2018 and 2027

Figure 46: North America Arthritis Therapeutics Market Attractiveness, By Country/Sub-region , 2019–2027

Figure 47: Europe Arthritis Therapeutics Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017–2027

Figure 48: Europe Arthritis Therapeutics Market Value Share (%), by Type, 2018 and 2027

Figure 49: Europe Arthritis Therapeutics Market Attractiveness, by Type, 2019–2027

Figure 50: Europe Arthritis Therapeutics Market Value Share (%), by Drug Class, 2018 and 2027

Figure 51: Europe Arthritis Therapeutics Market Attractiveness, by Drug Class, 2019–2027

Figure 52: Europe Arthritis Therapeutics Market Value Share (%), by Route of Administration, 2018 and 2027

Figure 53: Europe Arthritis Therapeutics Market Attractiveness, by Route of Administration, 2019–2027

Figure 54: Europe Arthritis Therapeutics Market Value Share (%), by Distribution Channel, 2018 and 2027

Figure 55: Europe Arthritis Therapeutics Market Attractiveness, by Distribution Channel, 2019–2027

Figure 56: Europe Arthritis Therapeutics Market Value Share (%), By Country/Sub-region /Sub-region, 2018 and 2027

Figure 57: Europe Arthritis Therapeutics Market Attractiveness, By Country/Sub-region /Sub-region, 2019–2027

Figure 58: Asia Pacific Arthritis Therapeutics Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017–2027

Figure 59: Asia Pacific Arthritis Therapeutics Market Value Share (%), by Type, 2018 and 2027

Figure 60: Asia Pacific Arthritis Therapeutics Market Attractiveness, by Type, 2019–2027

Figure 61: Asia Pacific Arthritis Therapeutics Market Value Share (%), by Drug Class, 2018 and 2027

Figure 62: Asia Pacific Arthritis Therapeutics Market Attractiveness, by Drug Class, 2019–2027

Figure 63: Asia Pacific Arthritis Therapeutics Market Value Share (%), by Route of Administration, 2018 and 2027

Figure 64: Asia Pacific Arthritis Therapeutics Market Attractiveness, by Route of Administration, 2019–2027

Figure 65: Asia Pacific Arthritis Therapeutics Market Value Share (%), by Distribution Channel, 2018 and 2027

Figure 66: Asia Pacific Arthritis Therapeutics Market Attractiveness, by Distribution Channel, 2019–2027

Figure 67 : Asia Pacific Arthritis Therapeutics Market Value Share (%), By Country/Sub-region /Sub-region, 2018 and 2027

Figure 68: Asia Pacific Arthritis Therapeutics Market Attractiveness, By Country/Sub-region /Sub-region, 2019–2027

Figure 69: Latin America Arthritis Therapeutics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027

Figure 70: Latin America Arthritis Therapeutics Market Value Share (%), by Type, 2018 and 2027

Figure 71: Latin America Arthritis Therapeutics Market Attractiveness, by Type, 2019–2027

Figure 72: Latin America Arthritis Therapeutics Market Value Share (%), by Drug Class, 2018 and 2027

Figure 73: Latin America Arthritis Therapeutics Market Attractiveness, by Drug Class, 2019–2027

Figure 74: Latin America Arthritis Therapeutics Market Value Share (%), by Route of Administration, 2018 and 2027

Figure 75: Latin America Arthritis Therapeutics Market Attractiveness, by Route of Administration, 2019–2027

Figure 76: Latin America Arthritis Therapeutics Market Value Share (%), by Distribution Channel, 2018 and 2027

Figure 77: Latin America Arthritis Therapeutics Market Attractiveness, by Distribution Channel, 2019–2027

Figure 78 : Latin America Arthritis Therapeutics Market Value Share (%), By Country/Sub-region /Sub-region, 2018 and 2027

Figure 79: Latin America Arthritis Therapeutics Market Attractiveness, By Country/Sub-region /Sub-region, 2019–2027

Figure 80: Middle East & Africa Arthritis Therapeutics Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017–2027

Figure 81: Middle East & Africa Arthritis Therapeutics Market Value Share (%), by Type, 2018 and 2027

Figure 82: Middle East & Africa Arthritis Therapeutics Market Attractiveness, by Type, 2019–2027

Figure 83: Middle East & Africa Arthritis Therapeutics Market Value Share (%), by Drug Class, 2018 and 2027

Figure 84: Middle East & Africa Arthritis Therapeutics Market Attractiveness, by Drug Class, 2019–2027

Figure 85: Middle East & Africa Arthritis Therapeutics Market Value Share (%), by Route of Administration, 2018 and 2027

Figure 86: Middle East & Africa Arthritis Therapeutics Market Attractiveness, by Route of Administration, 2019–2027

Figure 87: Middle East & Africa Arthritis Therapeutics Market Value Share (%), by Distribution Channel, 2018 and 2027

Figure 88: Middle East & Africa Arthritis Therapeutics Market Attractiveness, by Distribution Channel, 2019–2027

Figure 89: Middle East & Africa Arthritis Therapeutics Market Value Share (%), By Country/Sub-region /Sub-region, 2018 and 2027


List of Tables



Table 01: Global Arthritis Therapeutics Market Value (US$ Mn) Forecast, by Type, 2017–2027

Table 02: Global Arthritis Therapeutics Market Value (US$ Mn) Forecast, by Drug Class, 2017–2027

Table 03: Global Arthritis Therapeutics Market Value (US$ Mn) Forecast, by Route of Administration, 2017–2027

Table 04: Global Arthritis Therapeutics Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027

Table 05: Global Arthritis Therapeutics Market Value (US$ Mn) Forecast, by Region, 2017–2027

Table 06: North America Arthritis Therapeutics Value (US$ Mn) Forecast, by Type, 2017–2027

Table 07: North America Arthritis Therapeutics Value (US$ Mn) Forecast, by Drug Class, 2017–2027

Table 08: North America Arthritis Therapeutics Value (US$ Mn) Forecast, by Route of Administration
Table 09: North America Arthritis Therapeutics Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027

Table 10: North America Arthritis Therapeutics Market Value (US$ Mn) Forecast, By Country/Sub-region , 2017–2027

Table 11: Europe Arthritis Therapeutics Value (US$ Mn) Forecast, by Type, 2017–2027

Table 12: Europe Arthritis Therapeutics Value (US$ Mn) Forecast, by Drug Class, 2017–2027

Table 13: Europe Arthritis Therapeutics Value (US$ Mn) Forecast, by Route of Administration, 2017–2027

Table 14: Europe Arthritis Therapeutics Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027

Table 15: Europe Arthritis Therapeutics Market Value (US$ Mn) Forecast, By Country/Sub-region, 2017–2027

Table 16: Asia Pacific Arthritis Therapeutics Market Value (US$ Mn) Forecast, by Type, 2017–2027

Table 17: Asia Pacific Arthritis Therapeutics Market Value (US$ Mn) Forecast, by Drug Class, 2017–2027

Table 18: Asia Pacific Arthritis Therapeutics Market Value (US$ Mn) Forecast, by Route of Administration, 2017–2027

Table 19: Asia Pacific Arthritis Therapeutics Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027

Table 20: Asia Pacific Arthritis Therapeutics Market Value (US$ Mn) Forecast, By Country/Sub-region, 2017–2027

Table 21: Latin America Arthritis Therapeutics Value (US$ Mn) Forecast, by Type, 2017–2027

Table 22: Latin America Arthritis Therapeutics Value (US$ Mn) Forecast, by Drug Class, 2017–2027

Table 23: Latin America Arthritis Therapeutics Value (US$ Mn) Forecast, by Route of Administration, 2017–2027

Table 24: Latin America Arthritis Therapeutics Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027

Table 25: Latin America Arthritis Therapeutics Market Value (US$ Mn) Forecast, By Country/Sub-region, 2017–2027

Table 26: Middle East & Africa Arthritis Therapeutics Value (US$ Mn) Forecast, by Type, 2017–2027

Table 27: Middle East & Africa Arthritis Therapeutics Value (US$ Mn) Forecast, by Drug Class, 2017–2027

Table 28: Middle East & Africa Arthritis Therapeutics Value (US$ Mn) Forecast, by Route of Administration, 2017–2027

Table 29: Middle East & Africa Arthritis Therapeutics Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027

Table 30: Middle East & Africa Arthritis Therapeutics Market Value (US$ Mn) Forecast, By Country/Sub-region, 2017–2027